LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LEPU ScienTech Medical Technology has announced a board reshuffle, with Mr. Zheng stepping down as non-executive director and Mr. Zhu taking his place, effective December 9, 2024. Mr. Zhu, with extensive experience in the pharmaceutical sales sector, will also join the company’s Audit and Nomination Committees. These strategic changes are poised to bolster the company’s leadership and governance.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.